KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Non-Current Assets (2016 - 2025)

CareDx (CDNA) has disclosed Non-Current Assets for 13 consecutive years, with $156.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 12.12% to $156.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $564.5 million through Dec 2025, down 2.27% year-over-year, with the annual reading at $156.1 million for FY2025, 12.12% up from the prior year.
  • Non-Current Assets hit $156.1 million in Q4 2025 for CareDx, up from $132.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $156.8 million in Q1 2023 to a low of $102.5 million in Q1 2021.
  • Historically, Non-Current Assets has averaged $140.8 million across 5 years, with a median of $141.1 million in 2024.
  • Biggest five-year swings in Non-Current Assets: soared 39.67% in 2021 and later dropped 9.07% in 2024.
  • Year by year, Non-Current Assets stood at $133.3 million in 2021, then rose by 16.42% to $155.1 million in 2022, then fell by 1.31% to $153.1 million in 2023, then decreased by 9.07% to $139.2 million in 2024, then rose by 12.12% to $156.1 million in 2025.
  • Business Quant data shows Non-Current Assets for CDNA at $156.1 million in Q4 2025, $132.0 million in Q3 2025, and $137.0 million in Q2 2025.